glp-1 therapy in bellevue wa While receptor agonists are widely used for diabetes and weight management, clinicians should exercise extra caution older adults, who often have complex health profiles. These patients may face higher risk Weight Loss Management Bellevue &

The dulaglutide (Trulicity) shortage was resolved in June 2025

News-Medical, viewed 18 July 2026, Suggested Reading Sign in to keep reading We're committed to providing free access to quality science

McIntyre : In 60, 90 seconds, what I would say is that GLP-1s, without creative superlative, have the potential to transform the health span and the lifespan of people who are living with mental illnesses by targeting on-label considerations today and potentially targeting the underlying pathophysiology of the brain-based disorder tomorrow

In February, the FDA announced the semaglutide shortage was also over a win for both Eli Lilly and Novo Nordisk, respectively

These findings suggest that GLP-1 receptor agonists may be an option worth considering for type 2 diabetes patients at risk of RVO, potentially contributing to favorable long-term ocular outcomes and reducing the burden of visual impairment in this population, the researchers concluded in their paper.